Tommy Martinsson

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications

Erastin-induced ferroptosis enhances natural killer cell anti-tumor activity and offers therapeutic potential in neuroblastoma.

Erastin-induced ferroptosis enhances natural killer cell anti-tumor activity and offers therapeutic potential in neuroblastoma.

Journal: Frontiers in immunology
Published: November 04, 2025

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Journal: The Journal of molecular diagnostics : JMD
Published: April 08, 2025

DNA methylation profiling for molecular classification of neuroblastoma.

DNA methylation profiling for molecular classification of neuroblastoma.

Journal: Clinical epigenetics
Published: March 05, 2025

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.

Journal: Cancer letters
Published: February 25, 2025

Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report.

Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report.

Journal: Frontiers in oncology
Published: January 31, 2025

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma.

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma.

Journal: Biomarker research
Published: September 06, 2024

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Journal: Cancer research communications
Published: June 20, 2024

Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.

Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.

Journal: Journal of translational medicine
Published: June 17, 2024

Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance.

Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance.

Journal: Genes, chromosomes & cancer
Published: June 03, 2024

Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastoma.

Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastoma.

Journal: Molecular cancer
Published: May 18, 2024

Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report.

Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report.

Journal: Frontiers in oncology
Published: March 28, 2024

Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature.

Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature.

Journal: American journal of medical genetics. Part A
Published: January 23, 2024
Showing 1-12 of 71

Last Updated: 09/26/2026